Mieland, Andreas O.; Petrosino, Giuseppe; Dejung, Mario et al.
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells: PHARMACOLOGYLEUKEMIA. 2025 S. 13
Strik, Herwig; Efferth, Thomas; Kaina, Bernd
Artesunate in glioblastoma therapy: Case reports and review of clinical studiesPHYTOMEDICINE. Bd. 123. 2024
Faust, Dagmar; Wenz, Christine; Holm, Stefanie et al.
Cell-cell contacts prevent <i>t</i>-BuOOH-triggered ferroptosis and cellular damage in vitro by regulation of intracellular calciumARCHIVES OF TOXICOLOGY. Bd. 98. H. 9. 2024 S. 2953-2969
Alfayomy, Abdallah M.; Ashry, Ramy; Kansy, Anita G. et al.
Design, synthesis, and biological characterization of proteolysis targeting chimera (PROTACs) for the ataxia telangiectasia and RAD3-related (ATR) kinaseEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. Bd. 267. 2024
Kuhlen, Michaela; Schaller, Tina; Dintner, Sebastian et al.
Double Heterozygous Pathogenic Variants in <i>TP53</i> and <i>CHEK2</i> in Boy with Undifferentiated Embryonal Sarcoma of the LiverINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 25. H. 21. 2024
Sallbach, J.; Vilar, J. B.; Rasenberger, B. et al.
DUSP1 mediates glioblastoma resistance to temozolomide <i>via</i> inhibition of senescence inductionNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 397. 2024 S. S15-S15
Beltzig, Lea; Christmann, Markus; Dobreanu, Minodora et al.
Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma CellsANTICANCER RESEARCH. Bd. 44. H. 3. 2024 S. 901-910
Hieber, Christoph; Mustafa, Al-Hassan M.; Neuroth, Sarah et al.
Inhibitors of the tyrosine kinases FMS-like tyrosine kinase-3 and WEE1 induce apoptosis and DNA damage synergistically in acute myeloid leukemia cellsBIOMEDICINE & PHARMACOTHERAPY. Bd. 177. 2024
Fischer, Marten A.; Mustafa, Al-Hassan M.; Hausmann, Kristin et al.
Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cellsJOURNAL OF ADVANCED RESEARCH. Bd. 60. 2024 S. 201-214
Keggenhoff, Friederike L.; Castven, Darko; Becker, Diana et al.
PARP-1 selectively impairs <i>KRAS</i>-driven phenotypic and molecular features in intrahepatic cholangiocarcinomaGUT. Bd. 73. H. 10. 2024 S. 1712-1724